Re: Sabizabulin - mCRPC- used now for Covid 19.
in response to
by
posted on
Apr 24, 2022 11:50AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
BP by way of the several collaborations that are ongoing will need to know one way or another that ZEN-3694 works for them. So as I see it that needs to happen for any one of them to put a bid on Zenith, otherwise, they would have done it already.
Just saying ... Koo